DrMark Ledwidge

Prof. Mark Ledwidge (BSc Pharm, PhD, DBS, MPSI) is Co-Founder/Director of the Heartbeat Trust, H&L Pharma and Solvotrin Therapeutics. He is also UCD Professor in the School of Medicine at University College Dublin (Adjunct). Following graduation as a pharmacist and completion of a PhD in pharmaceutics at Trinity College, Dublin with Elan Corporation, Mark worked for Baxter Healthcare and Servier Laboratories in technical and marketing roles. He completed a Diploma in Business Strategy before co-founding the Heartbeat Trust, H&L Pharma and Solvotrin Therapeutics. Solvotrin successfully launched its first product Active Iron in 2017 and is currently developing anti-inflammatory drugs with applications in cancer chemoprevention.